Top Markets
#1 Akedo Akedo +179.90%
#2 TENDIES TENDIES +96.27%
#3 Threshold Network Threshold Network +47.05%
#4 Verus Coin Verus Coin +43.84%
#5 Mubarak Mubarak +27.69%
#6 Bitway Bitway +26.92%
#7 MultiversX MultiversX +23.94%
#8 Cash Cat Cash Cat +23.23%
#9 Palladium Network Palladium Network +22.69%
#10 aelf aelf +19.17%
Coin of the day
Akedo Akedo
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Shukra Pharmaceuticals Limited Shukra Pharmaceuticals Limited

Shukra Pharmaceuticals Limited

SHUKRAPHAR
Classement en actions #17792
Shukra Pharmaceuticals Limited is a prominent company engaged in the... Shukra Pharmaceuticals Limited is a prominent company engaged in the manufacturing and global distribution of pharmaceutical products. Their comprehensive product line addresses a broad spectrum of medical conditions, encompassing anti-infective medications (such as antibiotics, macrolides, quinolones, antivirals, antifungals, antimalarials, antiprotozoals, and anti-helminthics), central nervous system drugs (including sedatives, tranquilizers, antidepressants, and anti-manic agents), gastrointestinal treatments (like anti-emetics and anti-ulcer drugs), cardiovascular remedies (beta-blockers, diuretics), pain and inflammation management (analgesics, muscle relaxants, corticosteroids), anti-tuberculosis drugs, vitamin supplements, anti-allergy medications, and therapies for metabolic imbalances such as hyper- and hypoglycemia. The company was established on March 4, 1993, and its primary operations are directed from its headquarters in Ahmedabad, India.
Prix de l'action
$0.51647906
Capitalisation boursière
$226.16M
Changement (1 jour)
5.29%
Changement (1 an)
66.66%
Pays
IN
Échange Shukra Pharmaceuticals Limited (SHUKRAPHAR)

Catégorie

Healthcare
Ratio P/B pour Shukra Pharmaceuticals Limited (SHUKRAPHAR)
Ratio P/B au 2026 TTM : 0
Selon les derniers rapports financiers et le cours de l'action de Shukra Pharmaceuticals Limited, le ratio cours/valeur comptable actuel (TTM) est 0. À la fin de 2026, le ratio P/B était de 0.
Historique du ratio P/B pour Shukra Pharmaceuticals Limited de 2026 à 2026
Ratio P/B à la fin de chaque année
Année Ratio P/B Changez
Pas assez de données pour les dates fournies.
Ratio P/B pour des entreprises similaires ou concurrentes
Entreprise Ratio P/B Différence de Ratio P/B Pays
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
 4.0001 -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
 - -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
 - -
FR
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
 - -
IT
Sino Biopharmaceutical Limited Sino Biopharmaceutical Limited
Sino Biopharmaceutical Limited
1177.HK
 2.513 -
HK